Tissue-engineered in vitro models for studying lymphatic morphogenesis, pathogenesis, and drug delivery
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
The lymphatic system is a network consisting of lymphatic vessels and lymphoid organs such as lymph nodes (LNs), which drain excess interstitial fluid and eventually return it to the blood circulatory system via the thoracic duct and subclavian veins. It plays a key role in interstitial fluid homeostasis, adaptive immune response, biomolecular uptake (dietary lipid, albumin, amyloid beta, etc.), and tumor metastasis. Dysfunction of the lymphatic system thus can lead to various diseases, including lymphedema, lipedema, inflammatory diseases, autoimmune diseases, neurodegenerative diseases, cancer, and glaucoma. Despite the significant roles of lymphatics, its morphogenesis, pathogenesis, and drug delivery strategies are still not completely understood. Organ-on-chip systems combine microfabrication technology with biology, which enables in vitro models to recapitulate key aspects of human physiology and disease. In this dissertation, I discuss organ-on-chip models for studying different compartments of lymphatic vessels (initial lymphatics and collecting lymphatics) and organ-specific ocular lymphatics under physiological and pathological conditions. Specifically, I first describe the aqueous humor outflow model that incorporates trabecular meshwork and Schlemm’s canal, and TGF-β1/ALK5/VEGFC signaling axis in steroid-induced glaucoma. Then, I discuss the double-casting sacrificial 3D printing method to study lymphatic valve morphogenesis and inflammation-induced lymphatic valve dysfunction. Finally, I discuss the use of initial lymphatic vessel-on-chip devices to study nanoparticle delivery to lymphatic systems, revealing previously unappreciated size-dependent intracellular accumulation of nanoparticles in lymphatic endothelial cells.